Supernus Pharmaceuticals (SUPN) Pension (2011 - 2012)
Supernus Pharmaceuticals (SUPN) posted quarterly Pension of $279000.0 for Q4 2012, up 13.88% year-over-year from $245000.0 in Q1 2012, and up 1.45% on a QoQ basis from $275000.0 in Q3 2012.
Supernus Pharmaceuticals (SUPN) Pension (2011 - 2012) Analysis & Trends
Supernus Pharmaceuticals has reported Pension for 2 years, with the latest figure at $279000.0 in Q4 2012.
- Pension for Q4 2012 came in at $279000.0, up 13.88% year-over-year; the trailing twelve-month figure through Dec 2012 was $279000.0 (up 13.88% YoY), and the FY2012 annual result was $279000.0, up 13.88% from the prior year.
- Pension rose to $279000.0 in Q4 2012, from $275000.0 in the prior quarter.
- Over five years, Pension peaked at $279000.0 in Q4 2012 and troughed at $245000.0 in Q4 2011.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - |
| 10 | Supernus Pharmaceuticals | 2.74 Bn | 2.37 Bn | 185.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2012 | 279,000.00 |
| Sep 30, 2012 | 275,000.00 |
| Jun 30, 2012 | 259,000.00 |
| Mar 31, 2012 | 276,000.00 |
| Dec 31, 2011 | 245,000.00 |